INNOVUS PHARMACEUTICALS, INC. Retained Earnings
INNOVUS PHARMACEUTICALS, INC. had Retained Earnings of -$49.84 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2019-11-14
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$49.84M.
- 2019-06-30: Retained Earnings (Accumulated Deficit) -$47.61M.
- 2019-03-31: Retained Earnings (Accumulated Deficit) -$45.85M.
- 2018-12-31: Retained Earnings (Accumulated Deficit) -$43.86M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2019-09-30 | -$49.84M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$47.61M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$45.85M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$43.86M 10-Q · filed 2019-11-14 | |
| 2018-09-30 | -$41.70M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$39.25M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$37.41M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | -$35.64M 10-K · filed 2019-04-01 | -$35.64M 10-K · filed 2018-04-02 |
| 2017-09-30 | -$34.14M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$32.82M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$31.68M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$29.14M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$25.78M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$21.35M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$16.99M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$15.43M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$14.46M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$13.60M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$12.77M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$11.23M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$10.06M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$8.93M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $7.84M 10-Q · filed 2014-05-14 | |
| 2012-03-31 | -$2.41M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$2.35M 10-K · filed 2012-03-30 | |
| 2011-03-31 | -$24.53K 10-Q · filed 2012-05-10 | |
| 2010-12-31 | -$69.92K 10-K · filed 2012-03-30 |